UnknownNot Applicable

Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

Georgia50 participantsStarted 2020-08-01

Plain-language summary

The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:permanent atrial fibrillation with normal EF - Exclusion Criteria:AF with decreased EF \-

What they're measuring

12-ecg and echocardiography evaluation after 1 month treatment

Timeframe: 1 month

Trial details

NCT IDNCT04484688

SponsorAversi Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-09-01

View on ClinicalTrials.gov More Patient Participation trials